Page 3 - Weild Co News Today

VTB Group is launching a new business line that will focus on climate finance and carbon market operations both in Russia and internationally. Vladimir Litvak, who has over 25 years of experience in... | October 27, 2021

Robinhood stock gets off to rocky start Getty Images for Robinhood By Matt Egan, CNN Business Wall Street didn’t exactly roll out the red carpet to welcome Robinhood after its highly anticipated debut. The fast-growing trading company finished Thursday at $34.82, down 8% from its initial public offering price. Robinhood failed to score the first-day pop that new companies covet. And that’s despite Robinhood pricing its IPO at $38, the low end of the expected range. All of this suggests dema...

Robinhood stumbles in Wall Street debut Robinhood stumbles in Wall Street debut Posted: Jul 29, 2021 2:11 PM Updated: Jul 29, 2021 2:11 PM Posted By: By Matt Egan, CNN Business Wall Street didnt exactly roll out the red carpet to welcome Robinhood after its highly anticipated debut. The fast-growing trading company finished Thursday at $34.82, down 8% from its initial public offering price. Robinhood failed to score the first-day pop that new companies covet. And thats despite Robinhood prici...

Average Raise $308,978 On November 2, 2020, SEC Commissioner Jay Clayton announced an amendment to two regulations that have truly expanded investors access to the funding of startups, emerging growth companies, and affinity-based projects online. Companies can now use Reg CF to raise up to $5M USD, and RegA+ to raise up to $75M USD. Our webinar brings together two individuals who began this journey more than a decade ago. You will hear them reflect on their experiences and, more importantly, ...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Scopus BioPharma Announces Appointment of Additional Directors December 29, 2020 GMT (PRNewsfoto/Scopus BioPharma Inc.) NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatme...